Samil Pharmaceutical Co.,Ltd (KRX:000520)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,280
+60 (0.49%)
Last updated: Mar 24, 2025
16.95%
Market Cap 256.45B
Revenue (ttm) 219.70B
Net Income (ttm) -5.63B
Shares Out 21.23M
EPS (ttm) -313.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 67,473
Average Volume 170,130
Open 12,250
Previous Close 12,220
Day's Range 12,210 - 12,490
52-Week Range 7,800 - 19,500
Beta 0.35
RSI 44.24
Earnings Date Mar 14, 2025

About KRX:000520

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Se... [Read more]

Sector Healthcare
Founded 1947
Employees 585
Stock Exchange Korea Stock Exchange
Ticker Symbol 000520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.